Endometriosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a woman between 18 and 39 years old
- You have been found (through an MRI scan or keyhole surgery) to have signs of severe, deep endometriosis in the back part of the pelvis
- You are covered by a social security or health insurance plan
- You have been fully informed about the trial and have agreed to take part in writing
Who may not be able to join:
- You have a cyst on your ovary related to endometriosis that is larger than 5 mm
- You have previously had surgery specifically to treat severe deep endometriosis
- Your ovaries have significantly reduced function, based on specific hormone and ultrasound results (confirm with trial site)
- You are currently using, or have used in the past 3 months, a specific type of hormone treatment called a GnRH agonist (confirm with trial site)
- Your Body Mass Index (BMI) — a measure of body weight relative to height — is above 35
- You have gone through menopause
- You are currently taking part in another clinical trial that restricts you from joining additional studies
- You are under any form of legal guardianship or protection, or your freedom has been restricted by a legal or official decision
- You are currently pregnant, breastfeeding, or have recently given birth
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0033683346567
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percentage change in AMH (anti-mullerian hormone) levels between day 0 and month 12.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.